Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
1999 Nov 01;1285:1021-6. doi: 10.1038/sj.bjp.0702883.
Show Gene links
Show Anatomy links
In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound.
Le Brigand L
,
Virsolvy A
,
Manechez D
,
Godfroid JJ
,
Guardiola-Lemaître B
,
Gribble FM
,
Ashcroft FM
,
Bataille D
.
???displayArticle.abstract???
1. The MIN6 cell line derived from in vivo immortalized insulin-secreting pancreatic beta cells was used to study the insulin-releasing capacity and the cellular mode of action of S-22068, a newly synthesized imidazoline compound known for its antidiabetic effect in vivo. 2. S-22068, was able to release insulin from MIN6 cells in a dose-dependent manner with a half-maximal stimulation at 100 micronM. Its efficacy (8 fold over the basal value), which did not differ whatever the glucose concentration (stimulatory or not), was intermediate between that of sulphonylurea and that of efaroxan. 3. Similarly to sulphonylureas and classical imidazolines, S-22068 blocked K(ATP) channels and, in turn, opened nifedipine-sensitive voltage-dependent Ca2+ channels, triggering Ca2+ entry. 4. Similarly to other imidazolines, S-22068 induced a closure of cloned K(ATP) channels injected to Xenopus oocytes by interacting with the pore-forming Kir6.2 moiety. 5. S-22068 did not interact with the sulphonylurea binding site nor with the non-I1 and non-I2 imidazoline site evidenced in the beta cells that is recognized by the imidazoline compounds efaroxan, phentolamine and RX821002. 6. We conclude that S-22068 is a novel imidazoline compound which stimulates insulin release via interaction with an original site present on the Kir6.2 moiety of the beta cell K(ATP) channels.
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995, Pubmed
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995,
Pubmed
Berdeu,
Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas.
1994,
Pubmed
Chan,
The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1- and I2-sites.
1994,
Pubmed
Chan,
Pancreatic beta-cells express an imidazoline binding site that is distinct from I1 and I2 sites.
1995,
Pubmed
Chan,
Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
1990,
Pubmed
Chan,
The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
1991,
Pubmed
Chan,
Stimulation of insulin secretion by the imidazoline alpha 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site.
1993,
Pubmed
Dunne,
Block of ATP-regulated potassium channels by phentolamine and other alpha-adrenoceptor antagonists.
1991,
Pubmed
Dunne,
Potassium channels, imidazolines, and insulin-secreting cells.
1995,
Pubmed
Gribble,
Properties of cloned ATP-sensitive K+ currents expressed in Xenopus oocytes.
1997,
Pubmed
,
Xenbase
Gribble,
The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation.
1997,
Pubmed
,
Xenbase
Göke,
Characterization of the receptor for glucagon-like peptide-1(7-36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking.
1989,
Pubmed
Hughes,
Effect of secretagogues on cytosolic free Ca2+ and insulin release in the hamster clonal beta-cell line HIT-T15.
1988,
Pubmed
Inagaki,
Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.
1995,
Pubmed
Inagaki,
PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.
1996,
Pubmed
,
Xenbase
Ishihara,
Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets.
1993,
Pubmed
Jonas,
Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.
1992,
Pubmed
Lacombe,
The properties of imidazoline derivatives to stimulate insulin release by hamster pancreatic islets are probably due to alpha 2-adrenoceptor blockade but not to interaction with non-adrenergic idazoxan binding sites.
1993,
Pubmed
Le Brigand,
Stimulation of insulin release from the MIN6 cell line by a new imidazoline compound, S-21663: evidence for the existence of a novel imidazoline site in beta cells.
1997,
Pubmed
Nelson,
Increased cytosolic calcium. A signal for sulfonylurea-stimulated insulin release from beta cells.
1987,
Pubmed
Niki,
ATP-sensitive K-channels in HIT T15 beta-cells studied by patch-clamp methods, 86Rb efflux and glibenclamide binding.
1989,
Pubmed
Olmos,
Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
1994,
Pubmed
Panten,
Sulfonylurea receptors and mechanism of sulfonylurea action.
1996,
Pubmed
Pelé-Tounian,
Potent antihyperglycaemic property of a new imidazoline derivative S-22068 (PMS 847) in a rat model of NIDDM.
1998,
Pubmed
Pian-Smith,
Mobilization of Ca2+ from intracellular stores of pancreatic beta-cells by the calcium store blocker TMB-8.
1988,
Pubmed
Plant,
Phentolamine and yohimbine inhibit ATP-sensitive K+ channels in mouse pancreatic beta-cells.
1990,
Pubmed
Plant,
Clonidine inhibits ATP-sensitive K+ channels in mouse pancreatic beta-cells.
1991,
Pubmed
Poitout,
Insulin-secreting cell lines: classification, characteristics and potential applications.
1996,
Pubmed
Proks,
Phentolamine block of KATP channels is mediated by Kir6.2.
1997,
Pubmed
,
Xenbase
Sakura,
Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle.
1995,
Pubmed
Schmid-Antomarchi,
The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells.
1987,
Pubmed
Schulz,
Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release.
1988,
Pubmed
Schulz,
An insulin-releasing property of imidazoline derivatives is not limited to compounds that block alpha-adrenoceptors.
1989,
Pubmed
Tucker,
Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
1997,
Pubmed
,
Xenbase
Weng,
Effects of cholinergic agonists on diacylglycerol and intracellular calcium levels in pancreatic beta-cells.
1993,
Pubmed
